Stange EF - Search Results

1

Innate antimicrobial immunity in inflammatory bowel diseases.

Beisner J, Stange EF, Wehkamp J. Beisner J, et al. Among authors: stange ef. Expert Rev Clin Immunol. 2010 Sep;6(5):809-18. doi: 10.1586/eci.10.56. Expert Rev Clin Immunol. 2010. PMID: 20828289 Review.

2

[Biological therapies for treatment of chronic inflammatory bowel diseases. Status update].

Metzler J, Stange EF. Metzler J, et al. Among authors: stange ef. Med Klin (Munich). 2002 May 15;97(5):290-7. doi: 10.1007/s00063-002-1156-6. Med Klin (Munich). 2002. PMID: 12078390 Review. German.

3

Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease.

Wehkamp J, Fellermann K, Herrlinger KR, Baxmann S, Schmidt K, Schwind B, Duchrow M, Wohlschläger C, Feller AC, Stange EF. Wehkamp J, et al. Among authors: stange ef. Eur J Gastroenterol Hepatol. 2002 Jul;14(7):745-52. doi: 10.1097/00042737-200207000-00006. Eur J Gastroenterol Hepatol. 2002. PMID: 12169983

4

[Drug therapy of chronic inflammatory bowel diseases: what is new?].

Stange EF. Stange EF. Z Gastroenterol. 2002 Dec;40 Suppl 2:71-2. doi: 10.1055/s-2002-35910. Z Gastroenterol. 2002. PMID: 12467016 German. No abstract available.

5

[Therapy of chronic inflammatory bowel diseases].

Stange EF. Stange EF. Praxis (Bern 1994). 2002 Nov 20;91(47):2029-39. doi: 10.1024/0369-8394.91.47.2029. Praxis (Bern 1994). 2002. PMID: 12501498 Review. German.

6

Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis.

Schwab M, Schaeffeler E, Marx C, Fromm MF, Kaskas B, Metzler J, Stange E, Herfarth H, Schoelmerich J, Gregor M, Walker S, Cascorbi I, Roots I, Brinkmann U, Zanger UM, Eichelbaum M. Schwab M, et al. Gastroenterology. 2003 Jan;124(1):26-33. doi: 10.1053/gast.2003.50010. Gastroenterology. 2003. PMID: 12512026

7

[Therapy of chronic inflammatory bowel diseases with azathioprine, 6-mercaptopurine and 6-thioguanine. Clinico-pharmacologic aspects].

Schwab M, Herrlinger K, Schaeffeler E, Stange EF. Schwab M, et al. Among authors: stange ef. Dtsch Med Wochenschr. 2003 Feb 21;128(8):378-85. doi: 10.1055/s-2003-37378. Dtsch Med Wochenschr. 2003. PMID: 12594624 Review. German. No abstract available.

8

Lamina propria plasma cells in inflammatory bowel disease: intracellular detection of immunoglobulins using flow cytometry.

Dorn I, Schlenke P, Mascher B, Stange EF, Seyfarth M. Dorn I, et al. Among authors: stange ef. Immunobiology. 2002 Dec;206(5):546-57. doi: 10.1078/0171-2985-00203. Immunobiology. 2002. PMID: 12607730

9

Is there still a role for cyclosporine in the treatment of inflammatory bowel disease? Con argument.

Fellermann K, Lühmann D, Stange EF. Fellermann K, et al. Among authors: stange ef. Inflamm Bowel Dis. 2003 May;9(3):198-201; discussion 202-4. doi: 10.1097/00054725-200305000-00009. Inflamm Bowel Dis. 2003. PMID: 12792227 Review. No abstract available.

10

Crohn's disease: a defensin deficiency syndrome?

Fellermann K, Wehkamp J, Herrlinger KR, Stange EF. Fellermann K, et al. Among authors: stange ef. Eur J Gastroenterol Hepatol. 2003 Jun;15(6):627-34. doi: 10.1097/00042737-200306000-00008. Eur J Gastroenterol Hepatol. 2003. PMID: 12840673 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results